| |
|
|
|
|
|
ACULAR LS® is a non-steroidal anti-inflammatory (NSAID) indicated to reduce pain, burning and stinging following corneal refractive surgery. Approved by the U.S. Food and Drug Administration in 2003, the optimized 0.4 percent formulation of ACULAR LS® is clinically proven to block the source of post-corneal refractive surgical eye pain. ACULAR LS® has been shown to achieve significant and rapid pain relief.2
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
ALAMAST® is an eyedrop (available by prescription only) that is used to prevent itchy eyes caused by allergies.
LAMAST® works so you can quickly return to your daily routine. ALAMAST® provides rapid relief of itching with almost no burning or stinging of the eyes. In fact, ALAMAST® is gentile enough to use in patients as young as 3 years of age.
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
ALOCRIL®, approved by the U.S. Food and Drug Administration in 1999, is a prescription eye drop for itchy allergy eyes. An estimated 50 million Americans suffer from all types of allergies, and an estimated 4 percent of all allergy sufferers have eye allergies as their primary allergy.1
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
ALOCRIL®, approved by the U.S. Food and Drug Administration in 1999, is a prescription eye drop for itchy allergy eyes. An estimated 50 million Americans suffer from all types of allergies, and an estimated 4 percent of all allergy sufferers have eye allergies as their primary allergy.1
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
The first corticosteroid specifically designed for seasonal allergic conjunctivitis, Alrex® offers powerful relief against the whole symptom complex, i.e., itching, redness, burning, and photophobia.
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
Allergy Chronic Care
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
ELESTAT® is a fast-acting, long-lasting prescription eye drop that relieves the itch associated with allergies and feels soothing to the eyes upon instillation. An estimated 50 million Americans suffer from all types of allergies, and an estimated 4 percent of all allergy sufferers have eye allergies as their primary allergy.1 ELESTAT®, approved by the U.S. Food and Drug Administration in 2003, is indicated for the prevention of ocular itching associated with allergic conjunctivitis. ELESTAT® is co-promoted in the United States by Allergan and Inspire Pharmaceuticals.
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
ELESTAT® is a fast-acting, long-lasting prescription eye drop that relieves the itch associated with allergies and feels soothing to the eyes upon instillation. An estimated 50 million Americans suffer from all types of allergies, and an estimated 4 percent of all allergy sufferers have eye allergies as their primary allergy.1 ELESTAT®, approved by the U.S. Food and Drug Administration in 2003, is indicated for the prevention of ocular itching associated with allergic conjunctivitis. ELESTAT® is co-promoted in the United States by Allergan and Inspire Pharmaceuticals.
Important Safety Informat
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
If you suffer from irritated, watery, itchy eyes, you may have a condition called allergic conjunctivitis.
The clear, thin layer covering your eyeball and inside your eyelid is called the conjunctiva. Sometimes this layer becomes irritated and leads to a condition that doctors call conjunctivitis. If the irritation is caused by allergens (like pollen, pets, or dust) that get into your eye, it's allergic conjunctivitis.
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|
|
|
|
|
PATADAY™ ophthalmic solution (olopatadine hydrochloride 0.2) is Alcon's newest prescription allergy eye drop and is currently available only in the United States. With twice the concentration of PATANOL® solution, it is the first eye drop approved for once-a-day dosing for ocular itching associated with allergic conjunctivitis.
|
Company:
Date:
April 14, 2009
|
|
|
|
|
|